Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Melanoma 23Neoplasm Metastasis 11Leukemia, Myeloid, Acute 11Pancreatic Neoplasms 7Ovarian Neoplasms 7Carcinoma, Renal Cell 7Leukemia 6Kidney Neoplasms 6Breast Neoplasms 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Lymphoma 5Carcinoma, Non-Small-Cell Lung 5Neuroblastoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Colonic Neoplasms 4Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Gastrointestinal Neoplasms 3Congenital Abnormalities 3Vulvar Neoplasms 2Vaginal Neoplasms 2Uveal Melanoma 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2

Interventions

fludarabine 2aldesleukin 2Cyclophosphamide 2tivozanib 1fludarabine phosphate 1entinostat 1bintrafusp alfa protein, human 1atezolizumab 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Granisetron 1Electrocardiography 1Droperidol 1Doxylamine 1Diphenoxylate 1Diphenhydramine 1Codeine 1Cell Count 1Biopsy 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Vulvar Neoplasms × aldesleukin × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT05639972 2026-02-27

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Rutgers, The State University of New Jersey

Phase 1/2 Recruiting
15 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡